NEU 2.50% $15.59 neuren pharmaceuticals limited

The Glypromate failure, page-76

  1. 252 Posts.
    lightbulb Created with Sketch. 82
    Revive the Gypromate trial? Reed Miliary Hospital, if I correctly recall, made a mess of their ttrial with severely brain injured military personnel.
    (Pig of Steel Commented favorably this 27 October 2014 Post):

    Some years after Glypromate, while holidaying overseas, I met a medical research scientist. After getting to know him a little, while sharing some great walks on the Amalfi Coast in Italy, I told him about NEU.
    He researched the trial, and was critical of how it was conducted. 'On the cheap' was a phrase I remember he used. The cognitive skill testing used as the measuring stick of effectiveness was, he suggested, doomed to, at best, only moderate success.
    He suggested that such tests need to be conducted a long way apart because of what he called the "the experience effect". The more expensive, but definitively accurate assessment method of brain scans before and after the operation was what he would have done. He said he would have refused to have been part of the Glypromate trial.
    He did raise an interesting point though. He wondered whether cognitive tests of the subjects taken 6 months or more after their operations might have given a different result, when the "experience effect" had worn off, and the effectiveness of Glypromate could have been better assessed.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.